Preview Mode Links will not work in preview mode

MPR Weekly Dose

MPR Weekly Dose 124 — Novavax Vaccine Gains EUA; Comirnaty Adolescent Approval; OTC Switch for Contraceptive; Nasal Spray Available OTC; Dupilumab for Pediatric EoE

Jul 15, 2022

Novavax Emergency Use authorization; the Pfizer-BioNTech vaccine gets approval in adolescents; submission for oral contraceptive to be switched to over the counter; Astepro nasal spray gets over-the-counter approval; and Dupixent shows benefits in pediatric patients with eosinophilic esophagitis.

MPR Weekly Dose MPR 123 — Paxlovid Prescribing; Evusheld Dosing Updates; New Abuse-Deterrent Opioid; Lecanemab Priority Review; Morphine Tablet Recall

Jul 7, 2022

Pharmacists now allowed to prescribe Paxlovid; new dosing recommendations for Evusheld; abuse-deterrent opioid analgesic; priority review for early alzheimer disease treatment; morphine tablets recalled.

MPR Weekly Dose MPR 122 — Nasal Spray for Allergic Rhinitis; Qsymia Approval Expanded; Monkeypox Vaccine; Antibodies Shelf Life Extended; FDA Ban JUUL Products

Jul 1, 2022

New nasal spray for allergic rhinitis; weight management drug indication is expanded to include teens; monkeypox vaccine access; COVID-19 antibody shelf-life extension; JUUL banned in the US.